Decreased apoptosis in non-involved tissue from cancer-containing breasts

Journal of Pathology

Volumn 184, Issue 3, 1998, Pages 258-264

  Hassan, Howayda I ^a   Walker, Rosemary A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Breast cancer; Breast cancer development; Normal breast; Proliferation

Indexed keywords

DNA FRAGMENT; HISTONE; KI 67 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HISTONES; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MIDDLE AGED; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0031913758     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199803)184:3<258::AID-PATH999>3.0.CO;2-6     Document Type: Article

References (29)

1. Russo J, Russo IH. Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987; 57: 112-137.
2. Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978; 61: 1055-1063.
3. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-151.
4. Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 1990; 66: 1326-1335.
5. Tavassoli FA, Norris AJ. A comparison of the results of long-term follow-up for atypical ductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990; 65: 518-529.
6. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersen MD. Histologic types of benign breast disease and the risk of breast cancer. Cancer 1992; 69: 1408-1414.
7. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. J Am Med Assoc 1992; 267: 941-944.
8. Foote FW, Stewart FW. Comparative studies of cancerous versus non-cancerous breasts. Ann Surg 1945; 121: 6.
9. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231-273.
10. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer associated breasts. Hum Pathol 1985; 16: 796-807.
11. Walker RA, Cowl J, Dhadly PDS, Jones JL. Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts. Breast 1992; 2: 87-91.
12. Jones JL, Critchley DR, Walker RA. Alteration of integrin and stromal protein expression - a marker of pre-malignant change in breast. J Pathol 1992; 167: 399-406.
13. Ferguson DJP, Anderson TJ. Morphological evaluation of cell turnover in relation to menstrual cycle in the 'resting' human breast. Br J Cancer 1981; 44: 177-187.
14. Potten CS, Watson RJ, Williams GT, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988; 58: 163-170.
15. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-363.
16. Alison M, Chaudrey Z, Baker J, Lauder I, Pringle JH. Liver regeneration: a comparison of in-situ hybridisation for histone mRNA with bromodeoxy-uridine labelling for the detection of S-phase cells. J Histochem Cytochem 1994; 42: 1603-1608.
17. Ansari B, Coates PJ, Greenstein BD, Hall PA. In-situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8.
18. Ferguson DJF, Anderson TJ. Ultrastructural observations on cell death by apoptosis in the 'resting' human breast. Virchows Arch [Pathol Anat] 1981; 393: 193-203.
19. Allan DJ, Howell A, Roberts SA et al. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 1992; 167: 25-32.
20. Meyer JS. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labelling with tritiated thymidine. Hum Pathol 1977; 8: 67-80.
21. Meyer JS, Connor RE. Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labelling. Cancer 1982; 50: 746-751.
22. Anderson TJ, Ferguson DJP, Raab GN. Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982; 46: 376-382.
23. Russo J, Calaf G, Roi L, Russo IH. Influence of age and gland topography on cell kinetics of normal human breast tissue. J Natl Cancer Inst 1987; 78: 413-418.
24. Gerdes J, Lemke H, Baisch H, Wacher H-H, Schwab V, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
25. Chou MY, Chang ALC, McBride J, Donoff B, Gallagher GT, Wong DTW . A rapid method to determine proliferation patterns of normal and malignant tissue by H3mRNA in situ hybridization. Am J Pathol 1990; 136: 729-733.
26. Howell A, Anderson E, Laidlaw I, Schor A, Schor S, Potten C. Cyclical activity and 'ageing' of the human breast: clues to assessment of risk and strategies for prevention. In: Endocrine Therapy of Breast Cancer VI. ESO Monograph, 1994; 27-46.
27. Merritt AJ, Jones LS, Potten C. Apoptosis in murine intestinal crypts. In: Cotter T, Martin S, eds. Techniques in Apoptosis. Oxford: IRL Press, 1996; 269-299.
28. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer 1996; 74: 1743-1748.
29. Bargon RC, Daniel PT, Mapara MY, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax a expression in tumour cells correlates with resistance towards apoptosis. Int J Cancer 1995; 60: 854-859.